A Study to Evaluate MK-0482 for Relapsed/Refractory Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic Leukemia (CMML) (MK-0482-002)

Trial Identifier: 0482-002
Sponsor: MSD
Start Date: September 2021
Primary Completion Date: December 2023
Study Completion Date: December 2023
Condition: Leukemia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
Results Plain Language Summary - English
Results Plain Language Summary - EMEA Spanish

Trial Locations

Country Location
Israel, N/A Jerusalem, N/A, Israel, 9112001
Israel, N/A Ramat Gan, N/A, Israel, 5262100
Spain, Salamanca Salamanca, Spain, 37007
United States, NY Buffalo, NY, United States, 14263
United States, TX Houston, TX, United States, 77030